deferoxamine has been researched along with Sarcoidosis in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, M | 1 |
Kaneko, Y | 1 |
Hanaoka, H | 1 |
Kuwana, M | 1 |
Takeuchi, T | 1 |
Sekiguchi, M | 1 |
Okazaki, R | 1 |
Sano, H | 1 |
Sun, SS | 1 |
Tsai, SC | 1 |
Hung, CJ | 1 |
Tsai, PP | 1 |
Kao, CH | 1 |
1 review available for deferoxamine and Sarcoidosis
Article | Year |
---|---|
Acute kidney injury due to renal sarcoidosis during etanercept therapy: a case report and literature review.
Topics: Acute Kidney Injury; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Deferoxamine; D | 2015 |
2 other studies available for deferoxamine and Sarcoidosis
Article | Year |
---|---|
A Wig Sign.
Topics: Aged; Anti-Inflammatory Agents; Deferoxamine; Humans; Male; Octreotide; Prednisolone; Sarcoidosis; S | 2015 |
Tc-99m MDP and Ga-67 citrate scintigraphic findings in sarcoidosis with osseous involvement.
Topics: Bone Diseases; Deferoxamine; Humans; Male; Middle Aged; Octreotide; Radionuclide Imaging; Radiopharm | 2001 |